Internal Server Error

Solvias - About the company

Solvias is an acquired company based in Kaiseraugst (Switzerland), founded in 1999. It operates as a Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals. Solvias has raised an undisclosed amount in funding from Water Street. The company has 336 active competitors, including 15 funded and 84 that have exited. Its top competitors include companies like Nordic Bioscience, BioAgilytix and Advion.

Company Details

Solvias is offering integrated research and development services across the drug development services for the pharma and biotech and a range of other industries such as medical devices, cosmetics, agrochemicals, chemicals, and electronic materials. They have capabilities for offering analytical services, small molecule analysis, biopharmaceutical analysis, solid-state development, catalysis technology, custom synthesis manufacturing. Their service portfolio includes physicochemical characterization, comparability studies, methods development and validation, raw material testing, product release testing, stability storage/testing, cell-based bioassays, etc.
Social
Facebook
Email ID
*****@solvias.com
Phone Number
+41 **********
Key Metrics
Founded Year
1999
Location
Kaiseraugst, Switzerland
Stage
Acquired
Investors
Ranked
Employee Count
379 as on Jul 01, 2024
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Water Street (Jun 11, 2020)

Solvias's acquisition details

Solvias got acquired by Water Street and JLL Partners on Jun 11, 2020.
Click here to take a look at Solvias's acquisition in detail
Sign up to download Solvias' company profile

Solvias's funding and investors

Solvias has raised funding over 6 rounds. Its first funding round was on Jul 08, 2015. Its latest funding round was a Grant (prize money) round on Jan 01, 2021 for $*****. 1 investor participated in its latest round. Solvias has 3 institutional investors.

Here is the list of recent funding rounds of Solvias:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jan 01, 2021
3858988
Grant (prize money)
8694027
2341108
1058245
8132713
Feb 25, 2020
4620946
PE
8803300
2751270
4445717
4827577
Jan 05, 2018
4429925
Grant (prize money)
9542056
3665496
4932469
lockAccess funding benchmarks and valuations. Sign up today!

Solvias' founders and board of directors

Founder? Claim Profile

Solvias' employee count trend

Solvias has 379 employees as of Jul 24. Here is Solvias's employee count trend over the years:
Employee count trend for Solvias
lockUncover Solvias' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Solvias's Competitors and alternates

Top competitors of Solvias include Nordic Bioscience, BioAgilytix and Advion. Here is the list of Top 10 competitors of Solvias, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Nordic Bioscience
Nordic Bioscience
1996, Herlev (Denmark), Late Stage
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
-
62/100
2nd
Logo for BioAgilytix
BioAgilytix
2008, Durham (United States), Acquired
Global bioanalytical services leader, supporting drug development across various modalities
-
60/100
3rd
Logo for Solvias
Solvias
1999, Kaiseraugst (Switzerland), Acquired
Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals
-
58/100
4th
Logo for Advion
Advion
1993, Ithaca (United States), Acquired
Mass spectrometry, chromatography, and purification solutions for scientific advancement
$45.6M
50/100
5th
Logo for NCIMB
NCIMB
1982, United Kingdom, Early Stage
Provider of biorepository, microbial culture collection and microbiology services
$2.27M
49/100
6th
Logo for Alderley Analytical
Alderley Analytical
2013, Stockport (United Kingdom), Acquired
Provider of bioanalytical services for drug development programs and testing
$869K
49/100
7th
Global bioanalytical CRO providing comprehensive drug development services and advanced assay capabilities
-
-
49/100
8th
Logo for Dash Bio
Dash Bio
2024, Boston (United States), Series A
Provider of automated bioanalysis platform for accelerated clinical drug development
$17.5M
48/100
9th
Logo for NMS Labs
NMS Labs
1970, Willow Grove (United States), Unfunded
Provider of bioanalytical and central lab services, with special expertise in clinical toxicology and forensic testing
-
-
48/100
10th
Logo for ImmunXperts
ImmunXperts
2014, Charleroi (Belgium), Acquired
CRO specializing in human immune system based bioassay development services
$1M
47/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Solvias's competitors? Click here to see the top ones

Solvias's Investments and acquisitions

Solvias has acquired 2 companies including Cergentis and Chemic Laboratories. Solvias has not made any investments as of now.

News related to Solvias

lockFilter this list
Media has covered Solvias for a total of 5 events in the last 1 year, 3 of them have been about company updates.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Solvias

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford